These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 17130121)
21. IGF-1 increases laminin, cyclin D1, and p21Cip1 expression in glomerular mesangial cells: an investigation of the intracellular signaling pathway and cell-cycle progression. Jiang Y; Cheng DW; Levi E; Singh LP J Cell Biochem; 2006 May; 98(1):208-20. PubMed ID: 16408277 [TBL] [Abstract][Full Text] [Related]
22. beta-catenin mediates insulin-like growth factor-I actions to promote cyclin D1 mRNA expression, cell proliferation and survival in oligodendroglial cultures. Ye P; Hu Q; Liu H; Yan Y; D'ercole AJ Glia; 2010 Jul; 58(9):1031-41. PubMed ID: 20235220 [TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways. Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789 [TBL] [Abstract][Full Text] [Related]
24. Glycogen synthase kinase-3beta is involved in the process of myocardial hypertrophy stimulated by insulin-like growth factor-1. Seimi SK; Seinosuke K; Tsuyoshi S; Tomomi U; Tetsuaki H; Miki K; Ryuji T; Kenji I; Mitsuhiro Y Circ J; 2004 Mar; 68(3):247-53. PubMed ID: 14993781 [TBL] [Abstract][Full Text] [Related]
25. Cell cycle progression and activation of Akt kinase are required for insulin-like growth factor I-mediated suppression of apoptosis in granulosa cells. Hu CL; Cowan RG; Harman RM; Quirk SM Mol Endocrinol; 2004 Feb; 18(2):326-38. PubMed ID: 14593075 [TBL] [Abstract][Full Text] [Related]
26. Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3beta and degrades cyclin D1 in mammalian cells. Takahashi-Yanaga F; Taba Y; Miwa Y; Kubohara Y; Watanabe Y; Hirata M; Morimoto S; Sasaguri T J Biol Chem; 2003 Mar; 278(11):9663-70. PubMed ID: 12522140 [TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor-1 promotes cell cycle progression via upregulation of cyclin D1 expression through the phosphatidylinositol 3-kinase/nuclear factor-kappaB signaling pathway in FRTL thyroid cells. Ren M; Zhong X; Ma CY; Sun Y; Guan QB; Cui B; Guo J; Wang H; Gao L; Zhao JJ Acta Pharmacol Sin; 2009 Jan; 30(1):113-9. PubMed ID: 19060913 [TBL] [Abstract][Full Text] [Related]
28. Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy. Shimura T; Kakuda S; Ochiai Y; Kuwahara Y; Takai Y; Fukumoto M Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):540-8. PubMed ID: 21398050 [TBL] [Abstract][Full Text] [Related]
29. Apigenin suppresses insulin-like growth factor I receptor signaling in human prostate cancer: an in vitro and in vivo study. Shukla S; Gupta S Mol Carcinog; 2009 Mar; 48(3):243-252. PubMed ID: 18726972 [TBL] [Abstract][Full Text] [Related]
30. Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/S cell cycle progression via the activation of phosphatidylinositol 3'-kinase/Akt signaling pathway. Chakravarthy MV; Abraha TW; Schwartz RJ; Fiorotto ML; Booth FW J Biol Chem; 2000 Nov; 275(46):35942-52. PubMed ID: 10962000 [TBL] [Abstract][Full Text] [Related]
31. Tumor Necrosis Factor Alpha Stimulates Proliferation of Dental Pulp Stem Cells via Akt/Glycogen Synthase Kinase-3β/Cyclin D1 Signaling Pathway. Qin Z; Li Y; Li Y; Liu G J Endod; 2015 Jul; 41(7):1066-72. PubMed ID: 25843750 [TBL] [Abstract][Full Text] [Related]
35. PI3-kinase regulates survival of chronic lymphocytic leukemia B-cells by preventing caspase 8 activation. Plate JM Leuk Lymphoma; 2004 Aug; 45(8):1519-29. PubMed ID: 15370202 [TBL] [Abstract][Full Text] [Related]
36. PINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis. Akundi RS; Zhi L; Büeler H Neurobiol Dis; 2012 Jan; 45(1):469-78. PubMed ID: 21945539 [TBL] [Abstract][Full Text] [Related]
37. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor. Chiang WC; Teng CM; Lin SL; Chen YM; Tsai TJ; Hsieh BS Eur J Pharmacol; 2005 Jul; 517(1-2):1-10. PubMed ID: 15950964 [TBL] [Abstract][Full Text] [Related]
38. FTY720 induces apoptosis of human hepatoma cell lines through PI3-K-mediated Akt dephosphorylation. Lee TK; Man K; Ho JW; Sun CK; Ng KT; Wang XH; Wong YC; Ng IO; Xu R; Fan ST Carcinogenesis; 2004 Dec; 25(12):2397-405. PubMed ID: 15297371 [TBL] [Abstract][Full Text] [Related]
39. GSK-3beta inhibition: at the crossroad between Akt and mTOR constitutive activation to enhance cyclin D1 protein stability in mantle cell lymphoma. Dal Col J; Dolcetti R Cell Cycle; 2008 Sep; 7(18):2813-6. PubMed ID: 18769147 [TBL] [Abstract][Full Text] [Related]
40. Synergistic proliferative action of insulin-like growth factor I and 17 beta-estradiol in MCF-7S breast tumor cells. Hamelers IH; van Schaik RF; van Teeffelen HA; Sussenbach JS; Steenbergh PH Exp Cell Res; 2002 Feb; 273(1):107-17. PubMed ID: 11795951 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]